@techcrunch.com 2 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@techcrunch.com 2 years ago
Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 3 years ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@tech.eu 3 years ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu 3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@tech.eu 3 years ago
French medtech company UroMems raises €16 million Series B
@xconomy.com 4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@techcrunch.com 4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@techcrunch.com 5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@xconomy.com 5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com 5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas